Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma

Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

786 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 172
Recruiting: 93
Ph III recruiting: 9
Growth YoY: +32.4%
Industry share: 20%
Top sponsor: Ruijin Hospital
Termination share: 34.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (129)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03272633	Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies	terminated	Early Phase 1	2	Rutgers, The State University of New JerseyOTHER	1	Jun 26, 2023	clinicaltrials
NCT00704691	Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas	terminated	Early Phase 1	1	University of Alabama at BirminghamOTHER	1	Apr 20, 2012